IBSA inaugurates a new narrative in aesthetic medicine at the IMCAS World Congress 2026

IBSA (Institut Biochimique S.A.) is proud to participate in the IMCAS World Congress (International Master Course on Aging Science), the world's leading event dedicated to aesthetic medicine, dermatology, and plastic surgery, scheduled to take place in Paris from January 29 to February 1. This year, IBSA is strengthening its role as a pioneer in the sector, proposing a new narrative for aesthetic medicine focused on regeneration and presenting its portfolio of cutting-edge products.

Building on the success of previous editions, IBSA has organized a symposium, offering more than 650 international experts a platform for discussion on the most advanced regenerative approaches. The flagship symposium, “NAHYCO® FULL FACE: The New Frontier of Hybrid Regeneration” offered an in-depth look at regenerative aesthetic treatments for both women and men, including a live demonstration of an injectable treatment.

One of the most significant moments of this edition of the congress is the recognition of IBSA as a finalist in the prestigious Industry Innovation Awards for PROFHILO® STRUCTURA. This revolutionary product is specifically indicated for the restoration of facial adipose tissue and for the treatment of age-related skin dehydration and alteration of elastic fibers and collagen, associated with loss of skin firmness and tone. In vitro studies and clinical evidence have shown that PROFHILO® STRUCTURA acts through a physiological process that supports the vitality and differentiation of adipocytes, restoring volume and structure. Developed with IBSA's patented NAHYCO® Hybrid Technology, it achieves a record concentration of 45 mg/ml thanks to the stabilization of high and low molecular weight hyaluronic acids, without the use of chemical cross-linking agents.

Read the press release.